T2D patients with or without ASCVD were followed, and it was determined that dapagliflozin is noninferior to placebo with regard to MACE
Goldstein said he's filed one lawsuit to date in Middlesex, New Jersey, home to Novo Nordisk, the manufacturer of Ozempic and Wegovy, and plans to file others in the coming weeks
Ngo-Hamilton explains
It is remarkable that Vssc mutations have expanded greatly over the last three decades (Table 1) but that the specific mutations that confer the resistance have yet to be identified
If different shipments look different (color, clarity, viscosity), produce different effects, or arrive at different temperatures, your pharmacy partner may have quality control issues
Your pharmacist can review your full medication list for interactions